VERU INC. Public Float
VERU INC. (VERU) had Public Float of $64.10 million as of 2025-03-31, per its 10-K filed 2025-12-17.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2025-12-17
- 2025-03-31: Entity Public Float $64.10M.
- 2024-03-29: Entity Public Float $91.60M.
- 2023-03-31: Entity Public Float $77.70M.
- 2022-03-31: Entity Public Float $311.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-03-31 | $64.10M 10-K · filed 2025-12-17 |
| 2024-03-29 | $91.60M 10-K · filed 2024-12-16 |
| 2023-03-31 | $77.70M 10-K/A · filed 2024-04-01 |
| 2022-03-31 | $311.40M 10-K · filed 2022-12-05 |
| 2021-03-31 | $689.50M 10-K · filed 2021-12-02 |
| 2020-03-31 | $162.30M 10-K · filed 2020-12-10 |
| 2019-03-31 | $67.80M 10-K · filed 2019-12-12 |
| 2018-03-31 | $64.80M 10-K · filed 2018-12-13 |
| 2017-03-31 | $28.50M 10-K · filed 2018-01-02 |
| 2016-03-31 | $50.00M 10-K · filed 2016-12-12 |
| 2015-03-31 | $75.00M 10-K · filed 2015-12-02 |
| 2014-03-31 | $170.70M 10-K · filed 2014-12-02 |
| 2013-03-28 | $159.60M 10-K · filed 2013-12-03 |
| 2012-03-30 | $112.90M 10-K · filed 2012-12-04 |
| 2011-03-31 | $100.90M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |